Comparable stake leader
Peter Luo
SEC ownership of Adagene Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001818838.
Disclosed value leader
Peter Luo
Comparable rows
35/39
Latest evidence
05 Jun 2026
- Public ticker
- ADAG on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Peter Luo
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
35 of 39
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Peter Luo
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
05 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001818838
- Issuer location
- Jiangsu, China
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Adagene Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Peter Luo
Disclosed value leader
Peter Luo
Comparable rows
35/39
Latest evidence
05 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 11%
4 rows are not safely comparable across share classes.
13D/G row: Peter Luo
Showing 1-8 of 39 holder rows.
Quick read
Peter Luo leads the comparable SEC ownership view at 11%.
35 of 39 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Peter Luo's linked filing trail.
Comparable ownership
Top 5
Peter Luo
11%
Janus Henderson Group Ltd.
10%
Vincent C. Smith
8.7%
WuXi PharmaTech Healthcare Fund I...
7%
Jorey Chernett
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 39 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Peter Luo |
13D/G
3/4/5
HAN 2020 Irrevocable Trust · Chief Executive Officer, Director
|
11%
|
$34,369,007
9,390,439 shares
|
+$786,900 | 05 Jun 2026 |
| Janus Henderson Group Ltd. |
13D/G
JANUS HENDERSON GROUP PLC
|
10%
|
$25,666,664
6,666,666 shares
|
$0 | 30 Apr 2026 |
| Vincent C. Smith |
13D/G
Smith Vincent C
|
8.7%
|
$9,120,679
5,095,351 shares
|
+$2,258,166 | 31 Dec 2025 |
| WuXi PharmaTech Healthcare Fund I L.P. |
13D/G
|
7%
|
$8,187,161
4,121,815 shares
|
-$1,701,888 | 30 Sep 2025 |
| Jorey Chernett |
13D/G
Chernett Jorey
|
5.1%
|
$7,764,445
2,389,060 shares
|
$0 | 16 Mar 2026 |
| Panacea Innovation Ltd |
13D/G
Panacea Venture Healthcare Fund II, L.P.
|
3.8%
|
$4,469,175
2,250,000 shares
|
-$1,564,211 | 30 Sep 2025 |
| FIL Ltd |
13D/G
FIL Limited
|
1.8%
|
$1,320,902
936,810 shares
|
-$4,450,930 | 31 Mar 2025 |
| FMR LLC |
13D/G
|
0.9%
|
$933,679
473,949 shares
|
$0 | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$84,764.
Buys
$84,764
Insiders: 1
Sells
$0
Insiders: 0
Net
+$84,764
Shares: +23,245
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 23,245
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 23,245 | 0 | $84,764 | $0 | +$84,764 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to Adagene Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Yannick Chane-Du Mickael
Net 12M change
+$84,764
Latest report
06 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Yannick Chane-Du Mickael | Chief Strategy Officer | $1,519,455 | Mixed | 18 Mar 2026 | ||
| Peter Luo | Chief Executive Officer, Director | $653,020 | +$84,764 | +15% | Mixed | 06 Aug 2026 |
| Qinghai Zhao | Chief Manufacturing Officer | $423,195 | Mixed | 18 Mar 2026 | ||
| Man Kin Tam | Chief Financial Officer, Director | $378,894 | Mixed | 18 Mar 2026 | ||
| Ulf Grawunder | Director | $81,250 | Mixed | 17 Mar 2026 | ||
| Chunfang Gu | Executive Director of Finance | $22,896 | Mixed | 18 Mar 2026 | ||
| Ling Zhou | ED of Human Resources | $9,649 | Mixed | 18 Mar 2026 | ||
| Li Zhu | Director | Mixed | 18 Mar 2026 | |||
| Andy Yiu Leung Cheung | Director | Mixed | 18 Mar 2026 | |||
| Cuong Do V | Director | Mixed | 18 Mar 2026 |
Recent insider transactions for Adagene Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Peter Luo | ADAG | American Depositary Shares (ADS) | Purchase | 0.41% | $1,018 | $3.65 | 279 | 68,245 | 05 Aug 2026 | Direct |
| Peter Luo | ADAG | American Depositary Shares (ADS) | Purchase | 51% | $83,746 | $3.65 | 22,966 | 67,966 | 04 Aug 2026 | Direct |
* marks a reported price that did not pass the local price check.